ID: ALA5209150

Max Phase: Preclinical

Molecular Formula: C25H24N4O2

Molecular Weight: 412.49

Associated Items:

Representations

Canonical SMILES:  O=C(/C(=C/C=C/c1ccccc1)c1ccc(O)cc1)N1CCN(c2ncccn2)CC1

Standard InChI:  InChI=1S/C25H24N4O2/c30-22-12-10-21(11-13-22)23(9-4-8-20-6-2-1-3-7-20)24(31)28-16-18-29(19-17-28)25-26-14-5-15-27-25/h1-15,30H,16-19H2/b8-4+,23-9+

Standard InChI Key:  YUIPOWNGMINMSJ-KOTYPSLTSA-N

Associated Targets(non-human)

HT-22 3261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 412.49Molecular Weight (Monoisotopic): 412.1899AlogP: 3.63#Rotatable Bonds: 5
Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.07CX Basic pKa: 3.20CX LogP: 4.16CX LogD: 4.15
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: -0.70

References

1. Fang Y, Tan Q, Zhou H, Gu Q, Xu J..  (2022)  Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents.,  231  [PMID:35123296] [10.1016/j.ejmech.2022.114151]

Source